RhumbLine Advisers
CABA icon

RhumbLine Advisers’s Cabaletta Bio CABA Stock Holding History

RhumbLine Advisers’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$301K Buy
156,850
+25,210
+19% +$71K ﹤0.01% 3035
2026
Q2 		$409K Buy
+131,640
New +$433K ﹤0.01% 2888
2025
Q2 		– Sell
-61,388
Closed -$85K – 4157
2025
Q1 		$85K Sell
61,388
-2,033
-3% -$4.33K ﹤0.01% 3445
2024
Q4 		$144K Buy
63,421
+2,851
+5% +$10K ﹤0.01% 3355
2024
Q3 		$286K Sell
60,570
-1,310
-2% -$7.58K ﹤0.01% 3049
2024
Q2 		$463K Buy
61,880
+16,274
+36% +$199K ﹤0.01% 2740
2024
Q1 		$778K Buy
45,606
+1,459
+3% +$31.3K ﹤0.01% 2396
2023
Q4 		$1M Buy
44,147
+1,545
+4% +$26K ﹤0.01% 2251
2023
Q3 		$648K Buy
42,602
+13,622
+47% +$186K ﹤0.01% 2452
2023
Q2 		$374K Buy
+28,980
New +$315K ﹤0.01% 2879
2021
Q2 		– Sell
-14,694
Closed -$163K – 3003
2021
Q1 		$163K Sell
14,694
-760
-5% -$9.28K ﹤0.01% 2872
2020
Q4 		$193K Buy
15,454
+2,709
+21% +$35.1K ﹤0.01% 2849
2020
Q3 		$138K Sell
12,745
-2,284
-15% -$26.3K ﹤0.01% 2798
2020
Q2 		$167K Buy
+15,029
New +$115K ﹤0.01% 2833

Other funds holding CABA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

RhumbLine Advisers's CABA Position: Q3 2026 in Review

RhumbLine Advisers increased its Cabaletta Bio (CABA) stake by 19% in Q3 2026, buying an estimated $71K and bringing the position to 156,850 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #3035.

RhumbLine Advisers first reported a position in CABA in Q2 2020 and has held it in 14 quarters since. The position peaked at $1M in Q4 2023. 100 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • RhumbLine Advisers held 156,850 shares of Cabaletta Bio worth $301K as of Q3 2026.
  • RhumbLine Advisers bought 25,210 Cabaletta Bio shares in Q3 2026, an estimated $71K.
  • Cabaletta Bio made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3035 holding.
  • RhumbLine Advisers first reported a position in Cabaletta Bio in Q2 2020 and has held it in 14 quarters since.
  • RhumbLine Advisers's Cabaletta Bio position peaked at $1M in Q4 2023.
  • 100 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.